Myco
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Myco's published strategy and is not endorsed by, or produced in cooperation with, Myco. Company website
Strategic priorities
Myco operates across 4 stated priorities, with the most concrete near-term plan anchored on rapid manufacturing at scale.
Achieving "units of seconds" cycle times through proprietary thermo-pressing technology, enabling price parity with EPS and eliminating the grow-in-mold bottleneck that limits competitors.
Delivering a -1.305 kg CO₂e/kg cradle-to-gate footprint through upcycling of agricultural waste (sawdust, hemp), creating measurable Scope 3 benefits for B2B clients.
Strategic partnership with SEMA engineering to deploy semi-automated production systems achieving 300% capacity gains and 5-8x worker productivity improvements.
-
01
Rapid Manufacturing at Scale
Achieving "units of seconds" cycle times through proprietary thermo-pressing technology, enabling price parity with EPS and eliminating the grow-in-mold bottleneck that limits competitors.
-
02
Carbon-Negative Production
Delivering a -1.305 kg CO₂e/kg cradle-to-gate footprint through upcycling of agricultural waste (sawdust, hemp), creating measurable Scope 3 benefits for B2B clients.
-
03
Automation-First Operations
Strategic partnership with SEMA engineering to deploy semi-automated production systems achieving 300% capacity gains and 5-8x worker productivity improvements.
-
04
Regulatory-Driven Market Capture
Positioning as the compliant solution for EU PPWR 2030 bans, CBAM carbon accounting, and EPR fee modulation that penalizes hard-to-recycle EPS.
Challenges we see
- Operations Manufacturing
Production Scale-Up from Pilot to Industrial
MYCO operates from an 800 m² facility in Bzenec and is preparing for Series A funding to build a second-generation pilot line with 10x capacity. The transition from semi-automated pilot scale to full industrial throughput (15 pads/second) requires significant engineering and control system upgrades.
Scaling biological manufacturing introduces variability risks; without durable process control, inconsistent quality could damage B2B relationships where every corner pad must fit precisely into cardboard boxes.
- Digital Manufacturing
Biological Process Variability Control
Mycelium growth is inherently biological and variable. The SEMA machine introduced industrial control loops (pressure, temperature, time), but as MYCO scales to modular "mini-factory" deployments at customer sites, maintaining repeatability across distributed production becomes critical.
Crop failure or contamination in the facility could halt production. Biological variability without real-time monitoring may result in batch rejections and customer attrition.
- Compliance Regulatory
Digital Product Passport (DPP) Compliance
The EU's Ecodesign for Sustainable Products Regulation (ESPR) mandates Digital Product Passports for packaging, requiring QR-coded traceability of material composition, origin, and disposal instructions. MYCO's automated production via SEMA enables data logging, but a comprehensive digital traceability system is not yet implemented.
Inability to provide DPP-compliant data could exclude MYCO from premium B2B contracts with multinational corporations subject to strict ESG reporting requirements.
- Operations Integration
Multi-Site Orchestration for Modular Deployment
MYCO's 2025 roadmap includes containerized "modular turnkey solutions" deployable directly at customer sites (e.g., inside a Foxconn factory). This distributed manufacturing model requires centralized orchestration of remote production units while maintaining quality and traceability.
Without a unified IT/OT architecture, managing distributed mini-factories will create operational silos, inconsistent data, and quality control blind spots.
- Digital Operations
Quality Assurance for High-Value Applications
MYCO's FixPack serves high-precision applications like Meopta optical prisms and Camea industrial sensors, where compressive strength and ESD safety are critical. Current quality validation relies on manual inspection and post-production testing.
Where inline quality monitoring (e.g., computer vision) could allow defective products to reach customers, eroding trust in high-margin custom molding segments.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Production Automation Gap
MYCO's rapid forming technology is revolutionary but the current semi-automated SEMA machine represents first-generation automation. Scaling to 15 pads/second requires next-generation control systems with precise PLC orchestration and closed-loop feedback.
Deploy advanced industrial automation frameworks with real-time process control, enabling consistent quality at scale while reducing labor dependency in the expanding modular factory network.
-
Biological Process Monitoring Deficit
Mycelium cultivation involves complex biological parameters (moisture, temperature, contamination risk) that vary across substrate batches. Current monitoring lacks integrated real-time dashboards for proactive intervention.
Implement IoT sensor networks with advanced KPI visualization to transform biological process data into actionable insights, enabling predictive maintenance and contamination prevention.
-
Traceability and Compliance Data Silos
EU regulations (PPWR, ESPR, Green Claims Directive) require auditable data on material origins, carbon footprint, and disposal pathways. MYCO has LCA data but lacks an integrated platform for Digital Product Passport generation.
Build an ontology-driven data platform that consolidates production data, LCA metrics, and batch traceability into a compliance-ready Digital Product Passport system.
-
Distributed Manufacturing Control
MYCO's containerized mini-factory strategy will deploy production units at customer sites globally, but there is no unified architecture for remote monitoring, orchestration, and quality assurance across geographically dispersed assets.
Design a scalable IT/OT architecture with centralized orchestration and edge computing capabilities to manage distributed manufacturing while maintaining quality standards and real-time visibility.
-
Quality Control Vision Gap
High-value FixPack applications for optical and electronic components require precise quality validation. Current manual inspection cannot scale with rapid forming speeds and risks human error in critical measurements.
Deploy computer vision systems for inline quality inspection, detecting defects, dimensional accuracy, and surface consistency in real-time at production speeds.
What we'd propose
- Digital CDMO
Industrial Automation & Control System Upgrade
Design and implement next-generation PLC-based control systems to orchestrate MYCO's rapid forming production lines, enabling precise control of pressure, temperature, and timing parameters for consistent quality at 15 pads/second throughput.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Real-Time Bioprocess Monitoring Platform
Deploy an integrated IoT sensor network with advanced visualization dashboards to monitor biological cultivation parameters, enabling proactive contamination detection and process optimization across all production stages.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Digital Product Passport & Compliance Platform
Build an ontology-driven data platform that consolidates production batch data, LCA metrics, and material traceability into an automated Digital Product Passport system compliant with EU ESPR and PPWR requirements.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Distributed Manufacturing Orchestration Architecture
Design a scalable IT/OT architecture enabling centralized monitoring and control of geographically distributed mini-factory deployments, ensuring consistent quality standards and real-time operational visibility across all production sites.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Inline Quality Inspection with Computer Vision
Deploy AI-powered computer vision systems for real-time quality inspection of formed mycelium products, detecting dimensional deviations, surface defects, and structural inconsistencies at production speeds.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what Myco's own published ambition implies — not a perfect score.
- Process Automation 45 → 85
- SEMA partnership delivered 300% capacity gain but next-gen 15 pads/sec line requires advanced PLC orchestration and closed-loop control systems.
- Data Integration 35 → 80
- Production data exists in silos; LCA data separate from batch records; no unified platform for Digital Product Passport generation.
- Real-Time Monitoring 40 → 85
- Basic temperature/pressure controls implemented via SEMA; lacks comprehensive IoT sensor network and predictive analytics for contamination prevention.
- Quality Assurance 30 → 75
- Manual inspection dominates; no inline vision systems for dimensional/surface verification at scale production speeds.
- Compliance Readiness 50 → 90
- ISO-compliant LCA completed; PPWR/ESPR Digital Product Passport infrastructure not yet deployed; audit-ready traceability gaps.
- Scalability Architecture 25 → 80
- Single-site operation; containerized mini-factory strategy requires distributed IT/OT architecture not yet designed.
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
Think we've read this right?
Talk to usRelated reading
-
Accelerating lab and manufacturing operations with MTP – a modular approach
Among the various modular and plug-n-produce approaches, the Modular Type Package (MTP) approach has emerged as a game-changer.
-
OPC UA protocol support in embedded systems
OPC Unified Architecture (OPC UA) is a modern standard for data exchange, increasingly used in industrial environments.
-
Addressing sustainability in pharma & biotech
At A4BEE, we combine company social responsibility and sustainability needs with the path set by the company’s values and mission.
-
Vision systems and foam detection
Machine vision systems enhance industrial safety and quality by detecting defects and foam in real time for efficient, automated processes.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Myco, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].